Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18783480 | 0.94 | MRGPRX4 (0.49) | MRGPRX4LOXL2CYP4F2CYP4A11PKM | |
| SCHEMBL18775303 | 0.88 | PKM (0.44) | LOXL2PKMNPC1LMNA | |
| SCHEMBL18775298 | 0.84 | LOXL2 (0.59) | MRGPRX4LOXL2CYP4F2CYP4A11PKM | |
| SCHEMBL18775301 | 0.80 | KDM4E (0.45) | CYP1A2CYP2D6KDM4E | |
| SCHEMBL20143116 | 0.76 | RXRA (0.41) | MEN1KMT2AKDM4E | |
| SCHEMBL18775295 | 0.71 | PKM (0.48) | LOXL2CYP4F2CYP4A11PKMNPC1 | |
| SCHEMBL12797648 | 0.70 | LOXL2 (0.64) | MRGPRX4LOXL2CYP4F2CYP4A11NPC1 | |
| SCHEMBL18775300 | 0.69 | PKM (0.68) | LOXL2PKMNPC1KDM4E | |
| SCHEMBL12255430 | 0.69 | RXRA (0.54) | LMNA | |
| SCHEMBL16996823 | 0.69 | PKM (0.59) | LOXL2CYP4F2CYP4A11PKMNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9969931-B2 | Electrochromic composition and electrochromic element | CANON KABUSHIKI KAISHA (JP) | 2018-05-15 | — | — | US | disclosed |
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | SCN11A, ECH1, H1-0 | MRGPRX4 2203/4885LOXL2 4194/4885CYP4F2 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.